Cittadine Andrew's Form 4 filing
Monopar Therapeutics (MNPR) · filed Jun 21, 2024
- Accession no.
- 0001437749-24-021000
- Filed
- Jun 21, 2024
- Trade date
- Jun 18-20, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $25.5K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cittadine AndrewCIK 0001863624 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | Common Stock | PPurchaseAcquired | +12,000 | $0.86 | +$10,320 | 165,624 | Direct | |
| Jun 20, 2024 | Common Stock | PPurchaseAcquired | +20,508 | $0.74 | +$15,175.92 | 186,132 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.